Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
UBE Corporation (4208.T)
Tokyo, JP
Established in 1897 and headquartered in Tokyo, Japan, UBE Corporation, formerly known as Ube Industries, Ltd., is a globally diversified enterprise with core operations spanning chemicals, construction materials, and machinery. The company maintains a substantial international footprint, serving markets across Japan, North America, Europe, Africa, the Middle East, Thailand, India, Latin America, and other global regions. UBE's extensive chemicals division provides a wide range of products including synthetic rubber, engineering plastics, polyimide, polyethylene, caprolactam, nylon, plastic films, polypropylene molded products, fibers, fiber-reinforced plastics, industrial chemicals, liquefied gases, ammonium sulfate, battery components, separation membranes, fine chemicals, ceramics, high-purity chemicals, semiconductor gas products, and materials for polyurethane resins. Additionally, the company offers specialized chemical services such as contract manufacturing for active pharmaceutical ingredients (APIs) and intermediates, supplies aromatic SF5 compounds, markets FLUOLEAD (a novel nucleophilic fluorinating agent), and supports drug discovery and pipeline development initiatives. Within the construction materials segment, UBE supplies essential products like cement, ready-mixed concrete, soil stabilizing cement, general building materials, limestone, calcia, magnesia, and other specialty inorganic compounds. This division also actively engages in resource recycling and the distribution of coal. The machinery segment focuses on the production and supply of die-casting and injection molding machines, extrusion presses, UBE vertical mills, kilns, furnaces, dryers, water screening equipment, storage and transportation systems, bridges, steel structures, along with steel billets, cast iron, and various other steel products. Beyond these core areas, UBE Corporation is also involved in the generation and supply of electric power.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.42% | +1.21% | +0.64% | -15.01% | -1.70% | -5.61% | +10.68% | +8.26% | +0.46% | +26.91% | +19.41% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-5.0% Q1'26: +2.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+595.4% ★ Q1'26: -80.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.7% ★ Q1'26: +4.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.1% Q1'26: +3.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.0% Q1'26: +2.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×7.72× Q1'26: 7.84× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 4 Rev. Ana. 4 EPS Ana. |
Mar 2027 2 Rev. Ana. 1 EPS Ana. |
Mar 2028 5 Rev. Ana. 5 EPS Ana. |
Mar 2029 4 Rev. Ana. 4 EPS Ana. |
Mar 2030 3 Rev. Ana. 2 EPS Ana. |
Mar 2031 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
641.76B
est: 647.29B (-0.9%)
|
641.75B
est: 658.27B (-2.5%)
|
616.56B
est: 614.33B (+0.4%)
|
695.57B
est: 691.98B (+0.5%)
|
730.16B
est: 733.30B (-0.4%)
|
667.89B
est: 676.68B (-1.3%)
|
613.89B
est: 597.25B (+2.8%)
|
655.27B
est: 650.52B (+0.7%)
|
494.74B
est: 498.66B (-0.8%)
|
468.24B
est: 474.40B (-1.3%)
|
486.80B
est: 488.01B (-0.2%)
|
471.16B
466.51B – 484.70B
-3.5% YoY
|
484.66B
482.69B – 486.63B
+2.9% YoY
|
477.80B
433.72B – 542.02B
-1.4% YoY
|
438.40B
435.55B – 441.25B
-8.2% YoY
|
450.90B
429.18B – 482.12B
+2.9% YoY
|
445.10B
423.66B – 475.92B
-1.3% YoY
|
| EBITDA |
57.73B
est: 55.75B (+3.6%)
|
76.98B
est: 56.70B (+35.8%)
|
69.45B
est: 52.91B (+31.3%)
|
85.75B
est: 59.60B (+43.9%)
|
81.12B
est: 63.16B (+28.4%)
|
71.11B
est: 58.28B (+22.0%)
|
62.51B
est: 51.44B (+21.5%)
|
80.74B
est: 56.03B (+44.1%)
|
41.72B
est: 42.95B (-2.9%)
|
49.16B
est: 48.17B (+2.0%)
|
45.46B
est: 49.56B (-8.3%)
|
47.85B
47.37B – 49.22B
-3.5% YoY
|
49.22B
49.02B – 49.42B
+2.9% YoY
|
48.52B
44.04B – 55.04B
-1.4% YoY
|
44.52B
44.23B – 44.81B
-8.2% YoY
|
45.79B
43.58B – 48.96B
+2.9% YoY
|
45.20B
43.02B – 48.33B
-1.3% YoY
|
| EBIT |
24.00B
est: 19.52B (+23.0%)
|
41.26B
est: 19.85B (+107.9%)
|
34.82B
est: 18.52B (+88.0%)
|
50.25B
est: 20.87B (+140.8%)
|
44.55B
est: 22.11B (+101.5%)
|
34.03B
est: 20.40B (+66.8%)
|
25.90B
est: 18.01B (+43.8%)
|
44.04B
est: 19.62B (+124.5%)
|
16.21B
est: 15.04B (+7.8%)
|
22.46B
est: 21.56B (+4.2%)
|
18.05B
est: 22.17B (-18.6%)
|
21.41B
21.20B – 22.02B
-3.5% YoY
|
22.02B
21.93B – 22.11B
+2.9% YoY
|
21.71B
19.71B – 24.63B
-1.4% YoY
|
19.92B
19.79B – 20.05B
-8.2% YoY
|
20.49B
19.50B – 21.91B
+2.9% YoY
|
20.22B
19.25B – 21.63B
-1.3% YoY
|
| Net Income |
14.65B
est: 11.28B (+29.9%)
|
19.11B
est: 19.95B (-4.2%)
|
24.19B
est: 18.80B (+28.6%)
|
31.68B
est: 29.90B (+6.0%)
|
32.50B
est: 28.31B (+14.8%)
|
22.98B
est: 20.55B (+11.8%)
|
22.94B
est: 15.11B (+51.8%)
|
24.50B
est: 23.23B (+5.5%)
|
-7.03B
est: -6.73B (-4.5%)
|
28.98B
est: 30.13B (-3.8%)
|
-4.82B
est: -16.86B (+71.4%)
|
24.23B
20.82B – 25.92B
+243.7% YoY
|
26.36B
24.33B – 28.29B
+8.8% YoY
|
28.00B
20.39B – 34.98B
+6.2% YoY
|
22.44B
15.47B – 29.40B
-19.9% YoY
|
25.51B
23.91B – 27.80B
+13.7% YoY
|
29.99B
28.11B – 32.69B
+17.6% YoY
|
| SGA |
64.86B
est: 77.64B (-16.5%)
|
66.74B
est: 78.96B (-15.5%)
|
67.46B
est: 73.69B (-8.5%)
|
72.21B
est: 83.00B (-13.0%)
|
73.52B
est: 87.96B (-16.4%)
|
72.02B
est: 81.17B (-11.3%)
|
67.63B
est: 71.64B (-5.6%)
|
72.42B
est: 78.03B (-7.2%)
|
56.17B
est: 59.81B (-6.1%)
|
54.24B
est: 55.06B (-1.5%)
|
63.41B
est: 56.64B (+12.0%)
|
54.68B
54.14B – 56.25B
-3.5% YoY
|
56.25B
56.02B – 56.48B
+2.9% YoY
|
55.45B
50.34B – 62.91B
-1.4% YoY
|
50.88B
50.55B – 51.21B
-8.2% YoY
|
52.33B
49.81B – 55.96B
+2.9% YoY
|
51.66B
49.17B – 55.24B
-1.3% YoY
|
| EPS |
138.50
est: 116.15 (+19.2%)
|
180.60
est: 205.42 (-12.1%)
|
228.50
est: 193.63 (+18.0%)
|
301.65
est: 307.90 (-2.0%)
|
312.36
est: 291.62 (+7.1%)
|
227.33
est: 211.62 (+7.4%)
|
226.79
est: 155.66 (+45.7%)
|
249.31
est: 239.26 (+4.2%)
|
-72.54
est: -67.52 (-7.4%)
|
298.59
est: 310.40 (-3.8%)
|
-49.60
est: -171.28 (+71.0%)
|
245.92
214.48 – 266.91
+243.6% YoY
|
267.34
250.60 – 291.41
+8.7% YoY
|
288.32
210.00 – 360.30
+7.8% YoY
|
237.60
159.38 – 302.82
-17.6% YoY
|
262.70
246.25 – 286.35
+10.6% YoY
|
308.90
289.56 – 336.71
+17.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap Value ETF DISV | 0.30% | 14.12M | 0.42% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.29% | 1.13M | 0.58% |
| 3 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.13% | 737.0K | 0.58% |
| 4 | iShares MSCI Japan Small-Cap ETF SCJ | 0.13% | 328.2K | 0.50% |
| 5 | WisdomTree International SmallCap Dividend Fund DLS | 0.12% | 1.27M | 0.58% |
| 6 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.11% | 690.0K | 0.41% |
| 7 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.10% | 445.3K | 0.48% |
| 8 | Vanguard Global Value Equity Active ETF VVLU.AX | 0.10% | 891.5K | 0.28% |
| 9 | Dimensional - International Small Cap ETF DFIS | 0.10% | 5.72M | 0.39% |
| 10 | JPMorgan ETFs (Ireland) ICAV - Global Equity Multi-Factor UCITS ETF JPGL.L | 0.09% | 257.1K | 0.19% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yuki Nishida | President, Chief Executive Officer & Representative Director | 76M | male |
| Hirofumi Nonaka | Managing Executive Officer and GM of Performance Polymers & Chemicals Division | — | — |
| Hirotaka Ishikawa | CFO, CRO, Managing Executive Officer & Representative Director | — | male |
| Hisaaki Yokoo | Senior Managing Executive Officer & GM of Elastomer Div. | — | — |
| Ryo Kawamura | Managing Executive Officer, CHRO, CCO & Director | — | male |
| Futoshi Takase | Managing Executive Officer & General Manager of Ube Works | — | — |
| Shinya Takahashi | Managing Executive Officer & CSO | — | — |
| Shuko Horie | General Manager of Corporate Communications Department | — | — |
| Yoichi Funayama | Senior Managing Executive Officer & GM of Specialty Products Div | — | — |
| Yoichi Yoshida | CTO & Executive Officer | — | male |
| Shinsuke Tokumitsu | General Manager of Investor & Public Relations Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4208.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
